| Literature DB >> 21537023 |
Keith D Green1, Wenjing Chen, Sylvie Garneau-Tsodikova.
Abstract
Aminoglycoside-modifying enzymes (AMEs) constitute the most prevalent mechanism of resistance to aminoglycosides by bacteria. We show that aminoglycosides can be doubly modified by the sequential actions of AMEs, with the activity of the second AME in most cases unaffected, decreased, or completely abolished. We demonstrate that the bifunctional enzyme AAC(3)-Ib/AAC(6')-Ib' can diacetylate gentamicin. Since single acetylation does not always inactivate the parent drugs completely, two modifications likely provide more-robust inactivation in vivo.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21537023 PMCID: PMC3122451 DOI: 10.1128/AAC.00312-11
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191